Dr. Olufunmilayo Olopade Featured in The Scientist

Olufunmilayo I. Olopade, MD, FACP

The Scientist magazine featured Olufunmilayo Olopade, MD, Director of the University of Chicago Center for Clinical Cancer Genetics in a long profile in their latest issue. Olopade, who began her career as a groundbreaking physician-scientist studying the genetics of racial disparities in breast cancer, spoke about her work, what inspired her to become a doctor and how she adjusted to the snowy weather after moving to Chicago from Nigeria:

“My main project now continues to be to understand how to use genomics to improve global health and global cancer research. I’m building a big database of cancer patients I can use to inform the treatment of any patient, no matter where they are in the world. I think we can democratize how we prevent and treat cancer, so people on the periphery can take advantage of the research going on in the center. With health information tools, we can actually do that.”

Science Life last spoke to Dr. Olopade after the US Supreme Court decided the Myriad Genetics case, ruling that companies that isolate human genes cannot secure patents on them. She said the ruling had particular significance to her breast cancer research, because, “Genetic testing has remained prohibitively expensive in this country and without insurance and or third party payer approval, those who could benefit the most from knowing their mutation status have been denied access to life saving information.”

About Matt Wood (514 Articles)

Matt Wood is a senior science writer at the University of Chicago Medicine and nonfiction editor for Another Chicago Magazine.

%d bloggers like this: